Mesenteric traction syndrome or gut in distress.
The mesenteric traction syndrome (MTS) remains, seventeen years after its first designation as a distinct pathologic entity, an aspect of surgical practice that has received limited attention. Apart from its symptomatology, there is mostly speculation about its exact causes and pathophysiologic mechanisms. Even though full-blown MTS is rather rare, the advent of laparoscopic surgery has indicated that there are different stages of stress associated with open abdominal surgery. Some evidence points to the involvement of mast cell derived vasoactive mediators and suggests possible pharmacologic management.
Avgerinos
D V
DV
Theoharides
T C
TC
D005483:Flushing / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D006801:Humans; D007022:Hypotension / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D007422:Intestines / Q000601:surgery*; D007431:Intraoperative Complications / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D008407:Mast Cells / Q000187:drug effects / Q000378:metabolism; D013152:Splanchnic Circulation / Q000187:drug effects*; D013577:Syndrome; D013610:Tachycardia / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control